Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Regeneron Pharmaceuticals, Inc. (REGN) vs Royalty Pharma PLC (RPRX)

Regeneron Pharmaceuticals, Inc. and Royalty Pharma PLC are both Biotechnology companies. Regeneron Pharmaceuticals, Inc. is the larger, with a market value of $81.3B against $34.4B — 2.4× the size. Regeneron Pharmaceuticals, Inc. trades at the lower P/E: 18.8× against 40.1×. Royalty Pharma PLC grew revenue faster over the last twelve months: 10.0% against 9.29%. Royalty Pharma PLC has the higher net margin (32.0% vs 27.9%) and the lower return on invested capital (5.28% vs 9.34%). Across the 22 metrics below, Regeneron Pharmaceuticals, Inc. leads on 15 and Royalty Pharma PLC on 7.

Valuation

Metric REGN RPRX Biotechnology median
P/E 18.80 40.14 7.88
P/S 5.21 10.21 11.47
P/B 2.55 2.65 2.52
Price to free cash flow 22.66 19.77 21.16
EV/EBITDA 17.32 21.99 0.74
EV/Sales 4.87 13.42 10.73
Earnings yield 5.32% 2.49% (28.84%)
Free cash flow yield 4.41% 5.06% (23.03%)

Profitability

Metric REGN RPRX Biotechnology median
Gross margin 84.86% 100.00% 65.16%
Operating margin 24.74% 59.61% 0.00%
Net margin 27.86% 32.02% 0.00%
Free cash flow margin 23.01% 51.66% 0.00%
Return on equity 14.04% 8.42% (57.72%)
Return on assets 10.83% 4.26% (49.22%)
Return on invested capital 9.34% 5.28% 0.00%

Growth

Metric REGN RPRX Biotechnology median
Revenue growth (TTM) 9.29% 10.01% 5.64%
EPS growth (last fiscal year) 8.19% (5.52%) —
Revenue growth, 5-year CAGR 11.04% 2.30% 8.40%
Net income growth, 5-year CAGR 5.10% (4.59%) 0.00%

Health

Metric REGN RPRX Biotechnology median
Debt to equity 0.06 0.92 0.00
Current ratio 3.34 2.80 4.73
Net debt to EBITDA (1.43) 5.22 0.96

Dividend

Metric REGN RPRX Biotechnology median
Dividend yield — 3.09% 2.10%
Payout ratio 0.00 1.42 0.00

Size

Metric REGN RPRX Biotechnology median
Market cap 81.34b 34.35b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack